683 Mycophenolate mofetil improves liver tests in patients with autoimmune hepatitis (AIH)

Hepatology ◽  
2003 ◽  
Vol 38 ◽  
pp. 490-490 ◽  
Author(s):  
A ADAMS ◽  
R GISH ◽  
E WAKIL ◽  
N BZOWEJ ◽  
E DOO ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Liver Tests

scholarly journals Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis

2017 ◽  
Vol 15 (12) ◽  
pp. 1950-1956.e1 ◽  
Author(s):  
Cumali Efe ◽  
Hannes Hagström ◽  
Henriette Ytting ◽  
Rahima A. Bhanji ◽  
Niklas F. Müller ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Second Line ◽  
Efficacy And Safety ◽  
Second Line Therapy ◽  
Line Therapy

Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis

2019 ◽  
Vol 31 (7) ◽  
pp. 873-877 ◽  
Author(s):  
Zhen-Jun Yu ◽  
Lu-Lu Zhang ◽  
Ting-Ting Huang ◽  
Jian-Sheng Zhu ◽  
Ze-Bao He
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Standard Treatment

scholarly journals Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory to Standard Therapy

2004 ◽  
Vol 18 (5) ◽  
pp. 321-326 ◽  
Author(s):  
Shane M Devlin ◽  
Mark G Swain ◽  
Stefan J Urbanski ◽  
Kelly W Burak
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Alanine Aminotransferase ◽  
Standard Therapy ◽  
Conventional Treatment ◽  
Case Series ◽  
Therapeutic Options ◽  
Sparing Effect ◽  
Histological Remission ◽  
Steroid Sparing

There are limited therapeutic options available for patients with autoimmune hepatitis in whom conventional treatment fails. A case series of five patients unresponsive to or unable to take azathioprine, 6-mercaptopurine or corticosteroids who were treated with mycophenolate mofetil (MMF) is reported. While on MMF, alanine aminotransferase normalized or remained normal in all patients. MMF had a steroid-sparing effect and histological remission was demonstrated in one patient after seven months of MMF. One patient experienced an uncomplicated episode of pyelonephritis. In conclusion, MMF can effectively induce and maintain remission in refractory autoimmune hepatitis patients.

scholarly journals P35 Long-term remission is achievable in autoimmune hepatitis using Tacrolimus or Mycophenolate mofetil and results in regression of fibrosis

Gut ◽  
2011 ◽  
Vol 60 (Suppl 2) ◽  
pp. A16-A17 ◽  
Author(s):  
R. Scott ◽  
J. White ◽  
G. Atwal ◽  
N. Taylor ◽  
G. Mortimore ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis

Mycophenolate mofetil - a new treatment for autoimmune hepatitis?

2000 ◽  
Vol 33 (3) ◽  
pp. 480-481 ◽  
Author(s):  
Anil Dhawan ◽  
Giorgina Mieli-Vergani
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
New Treatment

Mycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?

2008 ◽  
Vol 103 (12) ◽  
pp. 3063-3070 ◽  
Author(s):  
Elke M. Hennes ◽  
Ye H. Oo ◽  
Christoph Schramm ◽  
Ulrike Denzer ◽  
Peter Buggisch ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Autoimmune Hepatitis ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document